Filing Flows › Whitehawk Therapeutics (WHWK) › Q1 2025 › vs Q1 2024
Whitehawk Therapeutics (WHWK) Q1 2025 vs Q1 2024 (year over year)
Whitehawk Therapeutics's revenue rose $1.8M (+33%) from $5.4M in Q1 2024 to $7.1M in Q1 2025.
Whitehawk Therapeutics, Q1 2025: revenue $7.1M (+34% year over year), operating margin -213.0%, net earnings $73.0M, operating cash flow −$11.9M. The chart draws each line against Q1 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q1 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $7.1M | $5.4M | $1.8M | +33% |
| Other income, net | $88.2M | $1.2M | $87.0M | 72× |
| Costs & expenses | $95.4M | $24.9M | $70.5M | +284% |
| Operating costs | $22.4M | $24.9M | −$2.5M | -10% |
| Net earnings | $73.0M | −$18.3M | $91.3M | — |
| Cost of revenue | $760K | $652K | $108K | +17% |
| Research & development | $8.8M | $13.6M | −$4.8M | -35% |
| SG&A | $12.8M | $10.6M | $2.2M | +21% |
| Operating cash sources | $86.6M | $5.0M | $81.6M | 17× |
| Depreciation | $57K | $50K | $7K | +14% |
| Share-based compensation | $1.7M | $3.6M | −$1.9M | -53% |
| Cash used in operations | $11.9M | $19.7M | −$7.8M | -40% |
| Working capital & other | $86.6M | $5.0M | $81.6M | 17× |
Questions
How much did Whitehawk Therapeutics's revenue grow year over year in Q1 2025?
Whitehawk Therapeutics's revenue rose $1.8M (+33%) from $5.4M in Q1 2024 to $7.1M in Q1 2025.